DEA Places Epidiolex in Schedule V

Cannabis Business Times
Sep 27, 2018, 9:24 am289 pts
The Drug Enforcement Administration placed Epidiolex in Schedule V today, marking the first time any drug derived from any part of the cannabis plant has been rescheduled in the U.S. The news brought an increase in pre-market trading for manufacturer GW Pharma, which trades on the Nasdaq under GWPH. “We are…

Read Article Share
Share Article
- email
- x.com
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Rubicon Organics secures $4 million in financing from Community Savings 80

Hemp Needs What Alcohol Already Has: A Clear Definition (Op-Ed) 71

Missouri Officials Propose Tightening Cannabis Licensing Rules 52

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.